文献速递传染病防控与疫情报告卫生政策与健康促进免疫规划

应对SARS-CoV-2高社区传播及相关死亡的公共卫生策略指南摘要(2020年12月)

Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths, December 2020.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2020-12-11

随着寒冷天气、室内活动增加、假日季及约50%传播来自无症状者,美国进入高水平传播阶段,需在个体和社区层面多管齐下实施所有循证公共卫生策略。本摘要强调CDC关键循证建议和可持续策略以减少传播,包括普遍佩戴口罩、保持身体距离、避免非必要室内空间和拥挤户外空间、增加检测、快速识别隔离感染者、追踪隔离检测密切接触者、保护高危人群、保护必要工作人员、推迟旅行、增加通风和手卫生及环境消毒、实现疫苗广泛可及和高社区覆盖。

要点

  • 美国进入高水平传播阶段,约50%传播来自无症状者,需多管齐下实施所有循证策略。
  • 核心策略包括普遍戴口罩、保持距离、避免非必要室内和拥挤户外空间、增加检测和接触者追踪。
  • 保护高危人群和必要工作人员,推迟旅行,加强通风、手卫生和环境消毒,并实现疫苗高覆盖。

核心结论

  • 美国处于SARS-CoV-2高水平社区传播阶段,需在个体和社区层面联合实施所有循证公共卫生策略以降低传播、长期后遗症或残疾和死亡。
  • 这些策略联合实施可改善健康公平、保留医疗能力、维持必要业务功能并支持幼儿园至12年级学校及学前班的面授教学。
  • 当前行动为未来疫苗广泛可及和高社区覆盖后安全回归日常活动提供桥梁。

研究设计与样本

  • 本文为CDC发布的总结性指南,汇总关键循证建议和可持续策略,基于美国疫情监测数据。
  • 2020年10月30日单日新增病例首超10万例,12月2日达单日高峰196,227例。

主要发现

  • 约50%的SARS-CoV-2传播来自无症状者。
  • 寒冷天气、更多室内时间、假日季和无症状传播共同导致美国进入高水平传播阶段。

关键数值与推荐

  • 建议普遍佩戴口罩。
  • 建议保持与他人的身体距离并限制面对面接触。
  • 建议避免非必要室内空间和拥挤户外空间。
  • 建议增加检测以快速识别和隔离感染者,并及时识别、隔离和检测COVID-19患者的密切接触者。
  • 建议保护重症或死亡高风险人群,并为必要工作人员提供充足个人防护装备和安全工作实践。

临床怎么用

  • 个体、家庭和社区应立即采取这些行动以降低当前高水平SARS-CoV-2传播。
  • 联合实施上述策略可减少传播、长期后遗症或残疾和死亡,并减轻大流行的经济影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In the 10 months since the first confirmed case of coronavirus disease 2019 (COVID-19) was reported in the United States on January 20, 2020 (1), approximately 13.8 million cases and 272,525 deaths have been reported in the United States. On October 30, the number of new cases reported in the United States in a single day exceeded 100,000 for the first time, and by December 2 had reached a daily high of 196,227.* With colder weather, more time spent indoors, the ongoing U.S. holiday season, and silent spread of disease, with approximately 50% of transmission from asymptomatic persons (2), the United States has entered a phase of high-level transmission where a multipronged approach to implementing all evidence-based public health strategies at both the individual and community levels is essential. This summary guidance highlights critical evidence-based CDC recommendations and sustainable strategies to reduce COVID-19 transmission. These strategies include 1) universal face mask use, 2) maintaining physical distance from other persons and limiting in-person contacts, 3) avoiding nonessential indoor spaces and crowded outdoor spaces, 4) increasing testing to rapidly identify and isolate infected persons, 5) promptly identifying, quarantining, and testing close contacts of persons with known COVID-19, 6) safeguarding persons most at risk for severe illness or death from infection with SARS-CoV-2, the virus that causes COVID-19, 7) protecting essential workers with provision of adequate personal protective equipment and safe work practices, 8) postponing travel, 9) increasing room air ventilation and enhancing hand hygiene and environmental disinfection, and 10) achieving widespread availability and high community coverage with effective COVID-19 vaccines. In combination, these strategies can reduce SARS-CoV-2 transmission, long-term sequelae or disability, and death, and mitigate the pandemic's economic impact. Consistent implementation of these strategies improves health equity, preserves health care capacity, maintains the function of essential businesses, and supports the availability of in-person instruction for kindergarten through grade 12 schools and preschool. Individual persons, households, and communities should take these actions now to reduce SARS-CoV-2 transmission from its current high level. These actions will provide a bridge to a future with wide availability and high community coverage of effective vaccines, when safe return to more everyday activities in a range of settings will be possible.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Honein MA, Christie A, Rose DA, et al. Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths, December 2020. MMWR Morb Mortal Wkly Rep. 2020. PMID: 33301434. doi:10.15585/mmwr.mm6949e2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。